Carmell Therapeutics (CTCX) Revenue & Revenue Breakdown
Carmell Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.91M
Latest Revenue (Q)
$395.99K
Carmell Therapeutics Revenue by Period
Carmell Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $1.91M | 3701.44% |
| 2024-12-31 | $50.32K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | - |
Carmell Therapeutics generated $1.91M in revenue during NA 2025, up 3701.44% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Carmell Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $395.99K | 1.08% |
| 2026-03-31 | $391.76K | -17.17% |
| 2025-12-31 | $472.98K | 11.06% |
| 2025-09-30 | $425.86K | -15.44% |
| 2025-06-30 | $503.61K | -1.32% |
| 2025-03-31 | $510.35K | 2819.81% |
| 2024-12-31 | $17.48K | -14.82% |
| 2024-09-30 | $20.52K | 66.55% |
| 2024-06-30 | $12.32K | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-3.73M | -200.00% |
| 2023-09-30 | $3.73M | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | - |
Carmell Therapeutics generated $395.99K in revenue during Q2 2026, up 1.08% compared to the previous quarter, and up 77.59% compared to the same period a year ago.